中文翻译
恭喜 $HIMS 的持有者，盘后股价回升 37%。 看来 $NVO 撤回了诉讼，并与 $HIMS 合作销售 NOVO 品牌的 GLP-1（胰高血糖素样肽-1）药物。 鉴于 $HIMS 曾交易于 70 美元，且一度成为被做空最多的股票之一。 看到因利好消息引发的逼空行情（Short Squeeze）我并不感到惊讶。
· 个股论点
$HIMS 与 $NVO 和解合作，盘后大涨 37% 或引发逼空。
英文原文
Congrats to the $HIMS holders, stock back up 37% after hours. It looks like $NVO dropped the lawsuit and partnered with $HIMS to sell NOVO branded GLP-1s. Given HIMS was once trading at $70 and became one of the most shorted stocks. Would not be surprised to see a short squeeze off the positive news.